Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration: A Pilot Study

NCT03313401 is registered in ClinicalTrials.gov with Ulucanlar Eye Training and Research Hospital as lead sponsor.

NCT NCT03313401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration: A Pilot Study
Lead sponsor
Ulucanlar Eye Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
June 30, 2017
Enrollment
34 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration